Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid

Biochemical and Biophysical Research Communications
RunTao HeXuguang Li

Abstract

The severe acute respiratory syndrome virus (SARS) is a coronavirus that instigated regional epidemics in Canada and several Asian countries in 2003. The newly identified SARS coronavirus (SARS-CoV) can be transmitted among humans and cause severe or even fatal illnesses. As preventive vaccine development takes years to complete and adverse reactions have been reported to some veterinary coronaviral vaccines, anti-viral compounds must be relentlessly pursued. In this study, we analyzed the effect of aurintricarboxylic acid (ATA) on SARS-CoV replication in cell culture, and found that ATA could drastically inhibit SARS-CoV replication, with viral production being 1000-fold less than that in the untreated control. Importantly, when compared with IFNs alpha and beta, viral production was inhibited by more than 1000-fold as compared with the untreated control. In addition, when compared with IFNs alpha and beta, ATA was approximately 10 times more potent than IFN alpha and 100 times more than interferon beta at their highest concentrations reported in the literature previously. Our data indicated that ATA should be considered as a candidate anti-SARS compound for future clinical evaluation.

References

Jun 1, 1979·Journal of Clinical Microbiology·O W SchmidtG E Kenny
May 29, 1992·Biochemical and Biophysical Research Communications·M Cushman, P Sherman
Mar 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·R A BucknallR M Chanock
Jan 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·M L StewartM T Huang
Mar 1, 1971·Journal of Bacteriology·F Siegelman, D Apirion
May 6, 2003·Science·Marco A MarraRachel L Roper
Nov 19, 2003·Biochemical and Biophysical Research Communications·Runtao HeXuguang Li
Feb 14, 2004·Science·Eliot Marshall, Martin Enserink
Mar 17, 2004·Respirology : Official Journal of the Asian Pacific Society of Respirology·John NichollsMalik Peiris
Mar 17, 2004·Biochemical and Biophysical Research Communications·Runtao HeXuguang Li
Mar 20, 2004·The Journal of Infectious Diseases·Ute StröherHeinz Feldmann
Mar 23, 2004·Nature Medicine·Lia van der HoekBen Berkhout
May 18, 2004·Biochemical and Biophysical Research Communications·Norio YamamotoNaoki Yamamoto
Jun 18, 2004·Emerging Infectious Diseases·Emily L C TanLawrence W Stanton

❮ Previous
Next ❯

Citations

Oct 16, 2007·Clinical Microbiology Reviews·Vincent C C ChengKwok Yung Yuen
Jul 26, 2008·The Journal of Antimicrobial Chemotherapy·Pavel KleinGiorgio Scalise
Apr 30, 2019·Frontiers in Microbiology·Jun-Gyu ParkLuis Martínez-Sobrido
Apr 28, 2010·PLoS Pathogens·Mickaël BouvetEtienne Decroly
Oct 2, 2009·Antiviral Chemistry & Chemotherapy·Ye ChenNeerja Kaushik-Basu
Feb 6, 2020·Chembiochem : a European Journal of Chemical Biology·Jared S MorseWenshe Ray Liu
May 26, 2006·Antimicrobial Agents and Chemotherapy·Krzysztof PyrcLia van der Hoek
Jan 24, 2013·Virology Journal·Rei-Lin Kuo, Shin-Ru Shih
May 27, 2020·Tropical Diseases, Travel Medicine and Vaccines·Rohit KumarNaveet Wig
Jan 22, 2010·The Journal of Antimicrobial Chemotherapy·Hui-Chen HungChing-Ping Tseng
Mar 3, 2005·Antiviral Chemistry & Chemotherapy·Shiro Shigeta, Toshihiro Yamase
Feb 15, 2019·Antiviral Chemistry & Chemotherapy·Jennifer C BeckerJohn V Williams
May 6, 2020·British Journal of Pharmacology·Hong ZhouXiao-Ming Meng
Apr 7, 2006·Expert Review of Anti-infective Therapy·Erik De Clercq
Oct 8, 2020·International Journal of Molecular Sciences·Celia AlonsoAitor Nogales
Nov 27, 2020·Microbial Pathogenesis·Mohammed A RohaimMuhammad Munir
Dec 9, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francesca PicarazziMattia Mori
May 30, 2020·International Journal of Biological Macromolecules·Biswajit NaikDhaneswar Prusty
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alon Ben DavidAmram Torgeman
Nov 14, 2006·Pharmacology & Therapeutics·Georgie FearIlya Raskin
Aug 28, 2021·Current Microbiology·Vaishnavi ChandramouliWilson Aruni
Oct 20, 2009·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Utpal GhoshNitai P Bhattacharyya
Dec 1, 2021·Proceedings of the National Academy of Sciences of the United States of America·Natacha S OgandoEric J Snijder

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.